Article: Preventing SARS-CoV-2 infection by blocking a tissue serine protease.
Therapeutic advances in infectious disease
2020 Volume 7, Page(s) 2049936120933076
Abstract: Currently, there are no proven pharmacologic interventions to reduce the clinical impact and prevent complications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, the cause of the ongoing Coronavirus Disease of 2019 (COVID- ... ...
Abstract | Currently, there are no proven pharmacologic interventions to reduce the clinical impact and prevent complications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, the cause of the ongoing Coronavirus Disease of 2019 (COVID-19) pandemic. Selecting specific pharmacological targets for the treatment of viral pathogens has traditionally relied in blockage of specific steps in their replicative lifecycle in human cells. However, an alternative approach is reducing the molecular cleavage of the viral surface spike protein of SARS-CoV-2 to prevent viral entry into epithelial cells. |
---|---|
Keywords | covid19 |
Language | English |
Publishing date | 2020-06-10 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 2728410-4 |
ISSN | 2049-937X ; 2049-9361 |
ISSN (online) | 2049-937X |
ISSN | 2049-9361 |
DOI | 10.1177/2049936120933076 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.